Category: biotech

.China’s Duality Biotherapeutics has filed (PDF) documentation for a Hong Kong IPO, looking for an undisclosed sum to electrical power an extensive pipe of antibody-drug

.Though Alkeus Pharmaceuticals’ dental eye condition resource neglected to significantly lessen geographic degeneration (GA) lesion development, the biotech is pointing out “clinically purposeful” end results

.While the biotech assets scene in Europe has reduced somewhat complying with a COVID-19 financing boom in 2021, a brand-new document from PitchBook proposes financial

.Merck &amp Co. has rapidly made back several of the expenses of its Spear Therapies acquistion, attracting $170 million beforehand through integrating the lead prospect

.Cullinan Therapy was actually excited good enough along with Port BioMed’s bispecific immune system reactor that it gave up $25 thousand in 2014 for the

.Welcome to today’s Chutes &amp Ladders, our summary of notable management hirings, shootings and retirings throughout the industry. Satisfy send out the compliment– or the

.Compass Pathways’ adventure to period 3 experimental depression records is actually taking longer than expected. With the trials overrunning by months, the biotech is letting

.Tip has actually stated period 3 information on its near-approval ache medicine prospect suzetrigine, shedding light on exactly how the non-opioid painkiller incorporates along with

.Cognition Therapeutics’ stage 2 SHINE trial has actually taken some of the radiance off the Alzheimer’s illness drug candidate CT1812. The oral sigma-2 opponent neglected

.Invite to this week’s Chutes &amp Ladders, our roundup of notable management hirings, firings and retirings all over the industry. Please deliver the good word–